RxSense, a Boston, MA-based healthcare technology company, received an investment from Parthenon Capital.
Terms of the investment were not disclosed.
The company intends to use the funds for various growth initiatives.
Led by Chairman and CEO Rick Bates, RxSense uses its proprietary technology platform to provide innovative prescription savings solutions to consumers and pharmacy benefits administration and analytics to enterprise customers. It offers:
- SingleCare®, a free prescription savings service available through its mobile app or discount cards available on Singlecare.com
- FamilyWize®, a prescription savings service that partners with some of the most respected community groups and healthcare providers in the country, including United Way Worldwide and the American Heart Association.
RxSense also announced that Jeffery Boyd and John Hayes have joined the company’s board of directors. Boyd is Chairman of the Board of Booking Holdings, Inc. and previously served as CEO of Booking Holdings and its predecessor Priceline Group. He was also Executive Vice President of Oxford Health Plans before joining Priceline. Boyd brings to RxSense unique expertise at the intersection of healthcare, technology and consumer brands. A proven private equity investor, Hayes is the co-founder of Great Hill Partners and led many investments in internet infrastructure, business services, SaaS companies and media sectors.
RxSense is headquartered in Boston with offices in New York City, greater Philadelphia and West Palm Beach, Fla.